Loading clinical trials...
Loading clinical trials...
Evaluation of the Performance of the VenusP-ValveTM System in Patients with Native RVOT Dysfunction
Conditions
Interventions
Transcatheter pulmonary valve implantation (TPVI)
VenusP-ValveTM System
Locations
1
United States
Venusmedtech of America
Irvine, California, United States
Start Date
June 11, 2024
Primary Completion Date
June 30, 2026
Completion Date
August 30, 2034
Last Updated
February 28, 2025
NCT03471936
NCT02590679
Lead Sponsor
Venus MedTech (HangZhou) Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions